乐发lll-追求健康,你我一起成长

ENG
Technology Platform
Oral Dosage Forms

Oral medications, including tablets, capsules, granules, and liquid formulations, play a vital role in modern medicine by providing effective treatment options for a wide range of diseases. Langhua Pharmaceutical has a well-established platform for the research, development, and production of oral dosage forms, offering the following services.

Scope of Services
  • Oral solution, suspension，and emulsion dosage form development
  • Oral tablet dosage form development:Immediate released/control released/delay released tablets and mini-tablets, oral disintegrating tablet, chewable tablet, effervescent tablet, bilayer tablet.
  • Oral capsule dosage form development: Immediate released/control released/delay released hard gelatin or HPMC capsules.
  • Oral particulate dosage form development: Immediate released/Control released/Delay released multiple particulates
  • Oral Control released/Delay released ion exchange resin dosage form development.
The Key Advantages of the Platform

  • The primary advantage of our platform is its ability to provide a one-stop solution for oral dosage form development, particularly for oral solid dosage forms, from clinical stages to commercial launch. Langhua Pharmaceutical has established a cGMP-compliant formulation production facility at its Shanghai R&D center, spanning nearly 1,000 square meters. This facility features strictly segregated functional areas equipped for the preparation of oral solid dosage forms, oral liquid dosage forms, and other non-sterile oral formulations, thereby meeting clients' clinical Phase I and II formulation needs. Additionally, Langhua has established strategic collaborations with external pharmaceutical companies to fulfill clients' clinical Phase III and commercial formulation requirements.

友情链接: